Paper36062803
TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells.
Rodrigues M and 4 others. Biochem J, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells. Papers, record 36062803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36062803
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MAP Kinase Kinase Kinases | Major topic |
| Myeloid Cells | Major topic |
| Toll-Like Receptors | Major topic |
| Animals | |
| Cytokines | |
| Humans | |
| Inflammation Mediators | |
| Lipopolysaccharides | |
| Macrophages | |
| Mice | |
| Mitogen-Activated Protein Kinase 14 | |
| MAP Kinase Kinase Kinase 7 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 209380/Z/17/Z | Wellcome Trust | United Kingdom | PubMed | |
| MR/R021406/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12548562 | Transgenic mice with hematopoietic and lymphoid specific expression of Cre. | Eur J Immunol | 2003 | https://conductscience.org/library/papers/12548562 | PubMed |
| 2 | 16186825 | Essential function for the kinase TAK1 in innate and adaptive immune responses. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16186825 | PubMed |
| 3 | 7499206 | PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7499206 | PubMed |
| 4 | 18690222 | The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18690222 | PubMed |
| 5 | 23918981 | Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice. | J Immunol | 2013 | https://conductscience.org/library/papers/23918981 | PubMed |
| 6 | 20485341 | Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. | Nature | 2010 | https://conductscience.org/library/papers/20485341 | PubMed |
| 7 | 17997719 | The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. | Biochem J | 2008 | https://conductscience.org/library/papers/17997719 | PubMed |
| 8 | 11390361 | MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. | Genes Dev | 2001 | https://conductscience.org/library/papers/11390361 | PubMed |
| 9 | 9697844 | Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. | Immunity | 1998 | https://conductscience.org/library/papers/9697844 | PubMed |
| 10 | 23376919 | IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production. | EMBO J | 2013 | https://conductscience.org/library/papers/23376919 | PubMed |
| 11 | 14670075 | TAB3, a new binding partner of the protein kinase TAK1. | Biochem J | 2004 | https://conductscience.org/library/papers/14670075 | PubMed |
| 12 | 24911653 | An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation. | Biochem J | 2014 | https://conductscience.org/library/papers/24911653 | PubMed |
| 13 | 11057907 | Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. | Cell | 2000 | https://conductscience.org/library/papers/11057907 | PubMed |
| 14 | 19592493 | An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19592493 | PubMed |
| 15 | 19465916 | E2 interaction and dimerization in the crystal structure of TRAF6. | Nat Struct Mol Biol | 2009 | https://conductscience.org/library/papers/19465916 | PubMed |
| 16 | 19621437 | Generation of a conditional CREB Ser133Ala knockin mouse. | Genesis | 2009 | https://conductscience.org/library/papers/19621437 | PubMed |
| 17 | 22226633 | TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. | Immunity | 2012 | https://conductscience.org/library/papers/22226633 | PubMed |
| 18 | 16260493 | TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. | Genes Dev | 2005 | https://conductscience.org/library/papers/16260493 | PubMed |
| 19 | 14592977 | Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. | EMBO J | 2003 | https://conductscience.org/library/papers/14592977 | PubMed |
| 20 | 27816943 | Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion. | Brain | 2017 | https://conductscience.org/library/papers/27816943 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42835768 | Transforming growth factor β-activated kinase 1 as a central integrator of immune-microbiota crosstalk in colitis (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42835768 | PubMed |
| 42394188 | Neutrophil Killing of Peptoanaerobacter stomatis Requires TAK1-Driven Degranulation. | J Innate Immun | 2026 | https://conductscience.org/library/papers/42394188 | PubMed |
| 41865324 | Artemisinin attenuates 3-nitropropionic acid-induced neurodegeneration via HMGB1/TLR4/NF-κB modulation in a rat model of huntington's disease. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/41865324 | PubMed |
| 41534849 | Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review. | J Enzyme Inhib Med Chem | 2026 | https://conductscience.org/library/papers/41534849 | PubMed |
| 40999870 | Disruption of NF-κB-Mediated Copper Homeostasis Sensitizes Breast Cancer to Cuproptosis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40999870 | PubMed |
| 38770174 | TAK1 in Vascular Signaling: "Friend or Foe"? | J Inflamm Res | 2024 | https://conductscience.org/library/papers/38770174 | PubMed |
| 38741011 | Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38741011 | PubMed |
| 38293990 | [Bioinformatics analysis and validation of the interaction between PML protein and TAB1 protein]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | https://conductscience.org/library/papers/38293990 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36062803
GET https://conductscience.org/api/papers/v1/36062803/references?page=2